268 related articles for article (PubMed ID: 31815035)
1. PGK1-mediated cancer progression and drug resistance.
He Y; Luo Y; Zhang D; Wang X; Zhang P; Li H; Ejaz S; Liang S
Am J Cancer Res; 2019; 9(11):2280-2302. PubMed ID: 31815035
[TBL] [Abstract][Full Text] [Related]
2. PGK1 : An Essential Player in Modulating Tumor Metabolism.
Duncan L; Shay C; Teng Y
Methods Mol Biol; 2022; 2343():57-70. PubMed ID: 34473315
[TBL] [Abstract][Full Text] [Related]
3. Roles and mechanisms of phosphoglycerate kinase 1 in cancer.
Chen Y; Cen L; Guo R; Huang S; Chen D
Bull Cancer; 2022 Dec; 109(12):1298-1307. PubMed ID: 36096942
[TBL] [Abstract][Full Text] [Related]
4. The basic functions of phosphoglycerate kinase 1 and its roles in cancer and other diseases.
Liu H; Wang X; Shen P; Ni Y; Han X
Eur J Pharmacol; 2022 Apr; 920():174835. PubMed ID: 35183535
[TBL] [Abstract][Full Text] [Related]
5. Regulation of phosphoglycerate kinase 1 and its critical role in cancer.
Zhang K; Sun L; Kang Y
Cell Commun Signal; 2023 Sep; 21(1):240. PubMed ID: 37723547
[TBL] [Abstract][Full Text] [Related]
6. Phosphoglycerate kinase (PGK) 1 succinylation modulates epileptic seizures and the blood-brain barrier.
Luo Y; Yang J; Zhang L; Tai Z; Huang H; Xu Z; Zhang H
Exp Anim; 2023 Nov; 72(4):475-489. PubMed ID: 37258131
[TBL] [Abstract][Full Text] [Related]
7. Phosphoglycerate kinase 1 (PGK1) in cancer: A promising target for diagnosis and therapy.
Fu Q; Yu Z
Life Sci; 2020 Sep; 256():117863. PubMed ID: 32479953
[TBL] [Abstract][Full Text] [Related]
8. The Neurogenic Compound P7C3 Regulates the Aerobic Glycolysis by Targeting Phosphoglycerate Kinase 1 in Glioma.
Chen W; Jia W; Wu C; Chen L; Sun K; Wang J; Ding B; Liu N; Xu R
Front Oncol; 2021; 11():644492. PubMed ID: 34221965
[TBL] [Abstract][Full Text] [Related]
9. Insulin and mTOR Pathway Regulate HDAC3-Mediated Deacetylation and Activation of PGK1.
Wang S; Jiang B; Zhang T; Liu L; Wang Y; Wang Y; Chen X; Lin H; Zhou L; Xia Y; Chen L; Yang C; Xiong Y; Ye D; Guan KL
PLoS Biol; 2015; 13(9):e1002243. PubMed ID: 26356530
[TBL] [Abstract][Full Text] [Related]
10. Synergistic effect of conformational changes in phosphoglycerate kinase 1 product release.
Liu Y; Li Y; Wu S; Li G; Chu H
J Biomol Struct Dyn; 2023 Nov; 41(19):10059-10069. PubMed ID: 36455998
[TBL] [Abstract][Full Text] [Related]
11. A novel inhibitor of PGK1 suppresses the aerobic glycolysis and proliferation of hepatocellular carcinoma.
Li M; Zhang A; Qi X; Yu R; Li J
Biomed Pharmacother; 2023 Feb; 158():114115. PubMed ID: 36516697
[TBL] [Abstract][Full Text] [Related]
12. Associations of PGK1 promoter hypomethylation and PGK1-mediated PDHK1 phosphorylation with cancer stage and prognosis: a TCGA pan-cancer analysis.
Shao F; Yang X; Wang W; Wang J; Guo W; Feng X; Shi S; Xue Q; Gao S; Gao Y; Lu Z; He J
Cancer Commun (Lond); 2019 Oct; 39(1):54. PubMed ID: 31578148
[TBL] [Abstract][Full Text] [Related]
13. Macrophage-Associated PGK1 Phosphorylation Promotes Aerobic Glycolysis and Tumorigenesis.
Zhang Y; Yu G; Chu H; Wang X; Xiong L; Cai G; Liu R; Gao H; Tao B; Li W; Li G; Liang J; Yang W
Mol Cell; 2018 Jul; 71(2):201-215.e7. PubMed ID: 30029001
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase activity of the glycolytic enzyme PGK1 regulates autophagy to promote tumorigenesis.
Qian X; Li X; Lu Z
Autophagy; 2017 Jul; 13(7):1246-1247. PubMed ID: 28486006
[TBL] [Abstract][Full Text] [Related]
15. PGK1 is a Potential Survival Biomarker and Invasion Promoter by Regulating the HIF-1α-Mediated Epithelial-Mesenchymal Transition Process in Breast Cancer.
Fu D; He C; Wei J; Zhang Z; Luo Y; Tan H; Ren C
Cell Physiol Biochem; 2018; 51(5):2434-2444. PubMed ID: 30537744
[TBL] [Abstract][Full Text] [Related]
16. Mitochondria-Translocated PGK1 Functions as a Protein Kinase to Coordinate Glycolysis and the TCA Cycle in Tumorigenesis.
Li X; Jiang Y; Meisenhelder J; Yang W; Hawke DH; Zheng Y; Xia Y; Aldape K; He J; Hunter T; Wang L; Lu Z
Mol Cell; 2016 Mar; 61(5):705-719. PubMed ID: 26942675
[TBL] [Abstract][Full Text] [Related]
17. Novel inhibitors targeting the PGK1 metabolic enzyme in glycolysis exhibit effective antitumor activity against kidney renal clear cell carcinoma in vitro and in vivo.
He Y; Luo Y; Huang L; Zhang D; Hou H; Liang Y; Deng S; Zhang P; Liang S
Eur J Med Chem; 2024 Mar; 267():116209. PubMed ID: 38354523
[TBL] [Abstract][Full Text] [Related]
18. [Influence of phosphoglycerate kinase 1 on metastasis and invasion of hepatoma cells and prognosis of liver cancer].
Zhang L; Wang YC; Xie XY; Chen J; Gao DM; Ren ZG
Zhonghua Gan Zang Bing Za Zhi; 2017 Jun; 25(6):446-451. PubMed ID: 28763863
[No Abstract] [Full Text] [Related]
19. Acetylation of PGK1 promotes liver cancer cell proliferation and tumorigenesis.
Hu H; Zhu W; Qin J; Chen M; Gong L; Li L; Liu X; Tao Y; Yin H; Zhou H; Zhou L; Ye D; Ye Q; Gao D
Hepatology; 2017 Feb; 65(2):515-528. PubMed ID: 27774669
[TBL] [Abstract][Full Text] [Related]
20. PGK1 facilities cisplatin chemoresistance by triggering HSP90/ERK pathway mediated DNA repair and methylation in endometrial endometrioid adenocarcinoma.
Zhou JW; Tang JJ; Sun W; Wang H
Mol Med; 2019 Mar; 25(1):11. PubMed ID: 30925862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
